Search
for

    Did you mean Receptor Tyrosine Kinase Signaling?
    Glossary Receptor Tyrosine Kinase Signaling

    cellular communication process involving protein receptors that regulate growth

    Receptor Tyrosine Kinase (RTK) Signaling is a cellular communication process where specific proteins on the cell surface, known as receptor tyrosine kinases, bind to signaling molecules like growth factors. This binding activates the receptors, causing them to add phosphate groups to certain tyrosines on themselves and other proteins, which then triggers a cascade of intracellular events that regulate cell growth, division, and survival. This pathway is crucial in many biological processes and is often implicated in diseases such as cancer when dysregulated.

    Related Terms

    Research 10 of 1000+

    1. Receptor tyrosine kinase Kit action in skin melanocytes: is it exclusively cell autonomous? Experimental Dermatology · 2015 · 1 citations
    2. Tyrosine kinase inhibition and grey hair The Lancet · 2003 · 59 citations
    3. Identification of key genes and signaling pathways related to Hetian sheep wool density by RNA-seq technology PLOS ONE · 2022 · 7 citations
    4. Hair graying and loss induced by imatinib mesylate The Journal of Dermatology · 2013 · 7 citations
    5. c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer Journal of Clinical Medical Research · 2021 · 4 citations
    6. Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation Current Issues in Molecular Biology · 2024
    7. Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS International Journal of Endocrinology · 2021 · 6 citations
    8. Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts Journal of Investigative Dermatology · 2004 · 11 citations
    9. Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies Biomedicines · 2025
    10. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →